Back
Enliven Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
21
ELVN
Enliven Therapeutics, Inc.
Last Price:
$16.27
Seasonality Move:
-8.68%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ELVN is experiencing slight buying pressure.
Enliven Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.75 | Sell |
| 20-day SMA: | 18.66 | Sell |
| 50-day SMA: | 20.07 | Sell |
| 200-day SMA: | 19.82 | Sell |
| 8-day EMA: | 17.01 | Sell |
| 20-day EMA: | 18.2 | Sell |
| 50-day EMA: | 19.38 | Sell |
| 200-day EMA: | 20.22 | Sell |
Enliven Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.14 | Sell |
| Relative Strength Index (14 RSI): | 37.38 | Sell |
| Chaikin Money Flow: | 6155 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.1 - 21.4) | Sell |
| Bollinger Bands (100): | (18.36 - 21.52) | Sell |
Enliven Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Enliven Therapeutics, Inc. Stock
Is Enliven Therapeutics, Inc. Stock a Buy?
-
Enliven Therapeutics, Inc. share price is 16.30 while ELVN 8-day simple moving average is 16.75, which is a Sell signal.
-
The stock price of ELVN is 16.30 while Enliven Therapeutics, Inc. 20-day SMA is 18.66, which makes it a Sell.
-
Enliven Therapeutics, Inc. 50-day simple moving average is 20.07 while ELVN share price is 16.30, making it a Sell technically.
-
ELVN stock price is 16.30 and Enliven Therapeutics, Inc. 200-day simple moving average is 19.82, creating a Sell signal.
ELVN Technical Analysis vs Fundamental Analysis
Sell
21
Enliven Therapeutics, Inc. (ELVN)
is a Sell
Is Enliven Therapeutics, Inc. a Buy or a Sell?
-
Enliven Therapeutics, Inc. stock is rated a SellThe current Enliven Therapeutics, Inc. [ELVN] share price is $16.30. The Score for ELVN is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
Enliven Therapeutics, Inc. Stock Info
Market Cap:
967.4M
Price in USD:
16.30
Share Volume:
510.9K
Enliven Therapeutics, Inc. 52-Week Range
52-Week High:
25.37
52-Week Low:
13.30
Sell
21
Enliven Therapeutics, Inc. (ELVN)
is a Sell
Enliven Therapeutics, Inc. Share Price Forecast
-
What is the Enliven Therapeutics, Inc. stock price today?The Enliven Therapeutics, Inc. stock price is 16.30 USD today.
-
Will ELVN stock go up or go down?Enliven Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Enliven Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Enliven Therapeutics, Inc. is overvalued.
Is Enliven Therapeutics, Inc. Stock a Buy?
-
Enliven Therapeutics, Inc. share price is 16.30 while ELVN 8-day exponential moving average is 17.01, which is a Sell signal.
-
The stock price of ELVN is 16.30 while Enliven Therapeutics, Inc. 20-day EMA is 18.20, which makes it a Sell.
-
Enliven Therapeutics, Inc. 50-day exponential moving average is 19.38 while ELVN share price is 16.30, making it a Sell technically.
-
ELVN stock price is 16.30 and Enliven Therapeutics, Inc. 200-day simple moving average is 20.22, creating a Sell signal.
Fundamental Analysis of Enliven Therapeutics, Inc.
Is Enliven Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.37 per share, and an increase next year of $0.32 per share.
Technical Analysis of Enliven Therapeutics, Inc.
Should I short Enliven Therapeutics, Inc. stock?
-
ELVN Moving Average Covergence Divergence (MACD) indicator is -1.14, suggesting Enliven Therapeutics, Inc. is a Sell
-
Enliven Therapeutics, Inc. Relative Strength Index (RSI) is 37.38, which suggest Enliven Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Enliven Therapeutics, Inc. is (17.1 - 21.4), which suggest Enliven Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Enliven Therapeutics, Inc. is (18.36 - 21.52), which suggest Enliven Therapeutics, Inc. is a Sell
* Enliven Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.